assessing intermediate clinical endpoints as potential surrogates for os in prostate cancer
Published 2 years ago • 123 plays • Length 3:29Download video MP4
Download video MP3
Similar videos
-
18:40
use of surrogate endpoints in oncology
-
2:09
current perspectives from clinical trials using parp inhibitors for prostate cancer
-
1:54
electronic pathology reporting and clinical trial matching for advanced prostate cancer
-
1:16:27
validating surrogate endpoints in oncology
-
11:11
lecture medical oncology - endpoints in clinical trials
-
0:52
clinical trial updates in prostate cancer at esmo 2022
-
1:10
dr. leonard gomella on surrogate endpoints in prostate cancer
-
2:17
how are clinical trials used in prostate cancer? | dana-farber cancer institute
-
24:46
the value of surrogate endpoints in the benefit-risk assessment of new drugs | gabe sonke, md, phd
-
31:53
lecture 2 - surrogate endpoints in oncology - reading and interpreting cancer trials
-
1:38
using mrd as an endpoint in clinical trials
-
6:16
all about clinical trials for advanced prostate cancer (royal) | prostate cancer staging guide
-
3:32
the use of surrogate endpoints in cll clinical trials
-
1:44
implementation of clinician-facing prostate cancer clinical trial decision tool
-
59:23
iddi webinar: current status of surrogates for survival in cancer trials
-
0:49
dr. dreicer on trial endpoints in prostate cancer
-
1:02
clinical trial for prostate cancer that is targeted and effective - the science of healing clip
-
1:23
genomic testing impacts treatment decisions in prostate cancer
-
1:52
clinical trial of enzamet shows it promising as prostate cancer treatment